Long‐term use of oral contraceptives and risk of invasive cervical cancer

International Journal of Cancer

Volumn 38, Issue 3, 1986, Pages 339-344

  Brinton, Louise A ^a   Huggins, George R ^b   Lehman, Herman F ^c   Mallin, Katherine ^d   Savitz, David A ^e   Trapido, Edward ^f   Rosenthal, Jeanne ^g   Hoover, Robert ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^d Department of Medicine   (United States)

^e UNIVERSITY OF COLORADO   (United States)

^f Papanicolaou Comprehensive Cancer Center ^*  (United States)

^g WESTAT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; ETHINYLESTRADIOL; GESTAGEN; MESTRANOL; ORAL CONTRACEPTIVE AGENT;

ADENOCARCINOMA; ADVERSE DRUG REACTION; CANCER INVASION; CARCINOGENESIS; CARCINOMA; CHEMICAL CARCINOGENESIS; CONTROLLED STUDY; DIAGNOSIS; DRUG MIXTURE; DRUG THERAPY; FEMALE GENITAL SYSTEM; HUMAN; MAJOR CLINICAL STUDY; ORAL DRUG ADMINISTRATION; PAPANICOLAOU TEST; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; THERAPY; UTERINE CERVIX CANCER;

ADENOCARCINOMA; ADULT; AGED; CARCINOMA, SQUAMOUS CELL; CONTRACEPTIVES, ORAL; FEMALE; HUMANS; MIDDLE AGED; RISK; TIME FACTORS; UTERINE CERVICAL NEOPLASMS;

EID: 0022522785     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.2910380307     Document Type: Article

References (25)

1. Oral contraceptives and cervical carcinoma
2. Cervical carcinoma and oral contraception
3. Cervical dysplasia: association with sexual behavior, smoking and oral contraceptive use?
4. EDITORIAL, Cervical epithelial dysplasia
5. EDITORIAL, Cervical neoplasia and the pill
6. Estrogen and progesterone receptor sites in malignancies of the uterine cervix, vagina, and vulva
7. The morphologic effects of oral contraceptive agents on the cervix
8. Characteristics of women with dysplasia or carcinoma in situ of the cervix uteri
9. Random digit dialing in selecting a population‐based control group
10. A computer program for the analysis of matched case‐ control studies
11. Preliminary analysis of oral contraceptive use and risk of developing premalignant lesions of the uterine cervix
12. The incidence of cervical cancer and duration of oral contraceptive use
13. Breast cancer in young women and use of oral contraceptives: possible modifying effect of formulation and age at use
14. Logistic disease incidence models and case‐control studies
15. Steroid contraceptive use and cervical dysplasia: increased risk of progression
16. Oral contraceptive use, sexual activity, and cervical carcinoma
17. A review of problems of bias and confounding in epidemiologic studies of cervical neoplasia and oral contraceptive use
18. Relationship of oral contraceptives to cervical carcinogenesis
19. Neoplasia of the cervix uteri and contraception: a possible adverse effect of the pill
20. Oral contraceptives and cervical cancer
21. Sampling methods for random digit dialing
22. Invasive cervical cancer and combined oral contraceptives
23. A case control study into the possible effects of birth control pills on pre‐clinical carcinoma of the cervix
24. Neoplasia and dysplasia of the cervix uteri and contraception: a possible protective effect of the diaphragm
25. Human genital cancer: synergism between two virus infections or synergism between a virus infection and initiating events?